Small molecules which reverse serous cystadenocarcinoma
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00010367
TitleSmall molecules which reverse serous cystadenocarcinoma
DescriptionThe L1000 database was queried in order to identify small molecule perturbations which reverse the serous cystadenocarcinoma gene expression signature in the Fallopian tube cell type.
Analysis URLhttp://amp.pharm.mssm.edu/L1000CDS2/#/result/58d1cebee467bea600fb8c0a
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis CuratorJoel.Dudley
CREEDS IDdz:58
Cell TypeFallopian tube
DO IDDOID:3114
Disease Nameserous cystadenocarcinoma
Organismhuman
UMLS CUIC0206701
L1000CDS2 parameters
Directionreverse
Characteristic Direction parameters
Control SamplesGSM277776, GSM277777, GSM277778, GSM277779, GSM277780, GSM277781, GSM277782, GSM277783, GSM277784, GSM277785, GSM277786, GSM277787, GSM277788, GSM277789, GSM277790, GSM277791, GSM277792, GSM277793, GSM277794, GSM277795, GSM277796, GSM277797, GSM277798, GS
Perturbed SamplesGSM277800, GSM277801, GSM277802, GSM277803, GSM277804, GSM277805, GSM277806, GSM277807, GSM277808, GSM277809, GSM277810, GSM277811, GSM277812
Tools used in the analysis
Dataset Accession
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
L1000CDS2
Published August 2016
An ultra-fast LINCS L1000 Characteristic Direction signature search engine
7756
Datasets used in the analysis
Keyword
Tool Name
GSE10971
Gene Expression Omnibus
Gene expression data from non-malignant fallopian tube epithelium and high grade serous carcinoma.
7
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.